Abstract-To provide a possible role of peripheral type benzodiazepine receptors in the regulation of glucocorticoid biosynthesis. We have examined the effect of diazepam on the corticoidogenic response to dibutyryl cyclic AMP in isolated bovine adrenal fasciculata cells. Diazepam alone (up to 100 'UM) had no effect on the corticoidogenesis.
Abstract-To provide a possible role of peripheral type benzodiazepine receptors in the regulation of glucocorticoid biosynthesis. We have examined the effect of diazepam on the corticoidogenic response to dibutyryl cyclic AMP in isolated bovine adrenal fasciculata cells. Diazepam alone (up to 100 'UM) had no effect on the corticoidogenesis.
Diazepam caused a dose-dependent potentiation of dibutyryl cyclic AMP-induced corticoidogenesis.
However, diazepam had no effect on the corticoidogenic response to ACTH and a high concentration of KCI. The poten tiating effect by diazepam was clearly detected after 90 min-incubation, and it was blocked by YM-684 (diazepam antagonist) and ML-236B (cholesterol de novo synthesis inhibitor). Diazepam caused no significant decrease of intracellular content of cholesteryl esters during the corticoidogenic response to dibutyryl cyclic AMP. When the cells were incubated in the presence of (+)-PN200-110, a potent voltage-dependent Ca channel inhibitor, the potentiating effect by diazepam was not affected in spite of a significant inhibition of dibutyryl cyclic AMP-induced corticoidogenesis.
These results indicate that the potentiating effect of diazepam on dibutyryl cyclic AMP-induced corticoidogenesis is due in part to the activation of the intracellular cholesterol supply system (cholesterol de novo synthesis) without any change of voltage-dependent Ca channels.
It has been established that benzodiaze pines, anxiolytic and anticonvulsant drugs, bind to at least two classes of binding sites termed central and peripheral type benzo diazepine receptors, respectively (1, 2). Cen tral type benzodiazepine receptors are closely linked to GABA receptors (3-5) and modulate the GABA-regulated chloride channels (6-8). In contrast, peripheral type benzodiazepine receptors are not linked to GABA-receptors (9, 10). These receptors have been identified in many peripheral tissues (11-13), in which the greatest receptor density is observed in the adrenal cortex (11, 13). However, the precise physiological function of these peripheral re ceptors is still not clear. routinely continued for 1 to 3 hr in a dark room. Diazepam and (+)-PN200-110 were dissolved in ethanol, and other chemicals were dissolved in the ordinary buffer for cell suspensions as described elsewhere (19, 20) . The final concentration of ethanol in the in cubation medium was less than 0.2%, a con centration which was shown to exert no demonstrable effect on corticoidogenesis. Analytical methods: Corticoids were ex tracted from whole cell suspensions with dichloromethane and measured fluorometri cally by the method of Silber et al. using cortisol as the standard (21) . Cellular free cholesterol and cholesteryl esters were as sayed by the enzymatic method of Gamble et al. (22) .
Chemicals: The sources of the various chemicals employed in this study were as fol Values are the mean±S.E. of triplicate determinations.
lows:
was from Sigma Chemical Co., Diazepam was from Wako Pure Chemical Industry, Japan; (+)-PN200-110 was kindly donated by Drs. R. Viret and F. Mitterhofer (Sandoz);
ML-236B and YM-684 (Ro 15 1788) were gifts from Sankyo Co., Japan and Yamanouchi Pharmaceutical
Co., Japan, re spectively. All other chemicals were reagent grade or better.
Results
Effect of diazepam on the corticoidogenic response of bovine adrenocortical cells to Bt2 cAM P, KCI and ACTH: As shown in Fig. 1 , diazepam potentiated the Bt2cAMP-induced corticoidogenesis in a dose-dependent man ner, but was without effect on the corti coidogenesis induced by either ACTH (100 pM) or a high concentration of KCI (10 mM). In the absence of steroidogenic agents, no effect by diazepam alone (up to 100 tiM) on the corticoidogenesis was observed in these experiments.
Effect of diazepam on Bt2cAMP-induced corticoidogenesis:
It can be seen from Fig. 2  that diazepam (100 tM) potentiates the dose dependent stimulation of the corticoidogenic response to Bt2cAMP in bovine adrenal fasciculata cells. Figure 3 shows the time-course of the corticoidogenic response to 0.5 mM Bt2cAM P with or without 100 uM diazepam. Bt2cAMP caused a linear increment of the corticoid pro duction until 90 min, and after then, the Bt2 Fasciculata cells were preincubated at 37'C for 10 min with (0) or without (Q) diazepam (100 4aM), and this was followed by a 2 hr-incubation with Bt2cAMP (indicated concentrations).
After incubation, corticoids were extracted with dichloromethane from cell suspensions and estimated fluorometrically.
Each value represents the mean±S.E. of triplicate determinations of two separate experiments. CAMP-induced corticoidogenesis was pre vented. However, in the presence of 100 tM diazepam, the corticoidogenic response to Bt2cAMP continued to increase even after 90 min incubation.
Effect of diazepam on intracellular content of cholesteryl esters: Figure 4 shows that diazepam (100 pM) does not cause a signifi cant decrease of intracellular content of cholesteryl esters under the same experi mental condition as shown in Fig. 3 . Similarly, no significant difference of the free cholesterol content was observed in the presence or ab sence of diazepam (data not shown).
Influence of several antagonists on poten tiating effect of diazepam: The experiments shown in Fig. 5 were designed to examine whether or not the potentiation by diazepam on Bt2cAMP-induced corticoidogenesis is due to the interaction of diazepam with its specific receptor. The potentiating effect by diazepam is blocked by YM-684, a diazepam receptor antagonist (23) .
ML-236B is known to he potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A re ductase (HMG-CoA reductase), which is the rate limiting enzyme in cholesterol de novo synthesis (24) . As shown in Fig. 6 , this in hibitor abolished the potentiating effect of diazepam on Bt2cAMP-induced corticoido Fasciculata cells were preincubated at 37 °C for 10 min with (40) or without (0) 100 uM diazepam, and the reaction was started by adding 0.5 mM Bt2cAMP. Samples of cell suspensions were taken at the indicated time for determination of cholesteryl esters as described under "Materials and Methods". Values are the mean±S.E. of triplicate determinations of three separate experiments. 
genesis.
When the cells were incubated with (+) PN200-110, a potent inhibitor of voltage dependent Ca channels (25), Bt2cAM P induced corticoidogenesis was inhibited in a dose-dependent manner. However, as shown in Fig. 7 , the potentiation by diazepam was not affected by this antagonist.
Discussion
In the present study, we have investigated the possible role of peripheral type benzo diazepine receptors in the regulation of ad renal glucocorticoid synthesis. Although the tissue distribution and biochemical properties of the peripheral type receptor have been ex amined, the precise physiological function of this receptor has not yet been elucidated. Peripheral type benzodiazepine receptors have been distinguished according to their ligand specificities (1, 26). Certain benzodiazepines (e.g., Ro 5-4864 and PK11195) are high af finity ligands for the peripheral type benzo diazepine receptor (11-13), but have no pharmacological activity in the modulation of the GABAA-regulated chloride channels linked to central type benzodiazepine receptor (9, 10). By using [3H] Ro 5-4864, peripheral type benzodiazepine receptors have been detected in a number of tissues, especially in the adrenal cortex (13). The binding of these specific ligands is displaced by dihydropyri dine calcium channel blockers, suggesting that one of the possible functions of the pe ripheral type receptor is to be coupled to voltage-dependent calcium channels (27 29) . In adrenal glomerulosa cells, Shibata et al. reported that peripheral type benzodiaze pine receptors have an inhibitory role in the regulation of aldosterone synthesis by inter acting with voltage-dependent calcium chan nels (14). However, the experiments shown in Fig. 7 indicate that in adrenal fasciculata cells, voltage-dependent calcium channels are not involved in the potentiating effect of diazepam on Bt2cAMP-induced corticoidogenesis.
It is obscure at present why diazepam is not able to potentiate the corticoidogenic re sponses to ACTH and KCI as shown in Fig. 1 . However, a possible explanation for these discrepancies is as follows: Especially in "bovine" adrenal fasciculata cells , either 100 pM ACTH or 10 mM KCI appears to stimulate corticoidogenesis via a mechanism dependent on calcium ions but not on cyclic AMP (19, 20) . Indeed, ACTH (100 pM) increases an intracellular cyclic AMP also in the "bovine" cells, but the increased concentration of cel lular cyclic AMP is one-thousand fold less than that by Bt2cAMP used in the present study (20) . Thus, the stimulatory mechanism of exogenously added Bt2cAMP on corti coidogenesis might be different from those of ACTH and KCI.
In an attempt to elucidate the mechanism of action of diazepam on the potentiating effect, the intracellular cholesterol dynamics under the corticoidogenic response to Bt2 cAMP plus diazepam were observed. We have purified a novel protein termed des-endoze pine whose synthesis is tightly coupled to acute adrenal steroidogenesis (15, 16), (K. Yanagibashi et al., unpublished data) . This protein appears to bind to the adrenal peripheral type benzodiazepine receptor (30) and stimulate cholesterol delivery to the inner mitochondrial membrane (15). Studies are now being undertaken in this laboratory to determine the precise mechanism of des endozepine on cholesterol mobilization and also the interrelation between this protein and benzodiazepines. Our results shown in Figs. 4 and 6 suggest that the potentiating effect of diazepam is due in part to the activation of the intracellular cholesterol supply system (cho lesterol de novo synthesis). This is in good agreement with the results reported by Sekimoto et al. (31) that the corticoidogenic action of Bt2cAMP in bovine adrenal fascicu lata cells is mediated by the activation of cholesterylester hydrolase, and the derived free cholesterol from the cholesteryl esters is one of the essential sources for the substrate of corticoidogenesis within the 90 min-incu bation. By contrast, it is likely that the ac tivation of cholesterol de novo synthesis is a possible site of the potentiating action of diazepam (Fig. 6) . In order to determine whether or not the potentiating action of diazepam is mediated by a specific interaction with benzodiazepine receptors, we evaluated the effect of the diazepam antagonist YM-684 (Ro 15-1788) on the diazepam-induced potentiation. As shown in Fig. 5 , the potentiating effect of diazepam is inhibited by YM-684 in a concen tration range (~ ,uM) that is consistent with its pharmacological effect on the rat hip pocampal slice (32, 33) . These results suggest that the antagonist not only binds to the central type receptor with high affinity but may also intreract less strongly or non selectively with the peripheral type receptor (23, 34) .
The present experiments indicate that a possible role of peripheral type benzodiaze pine receptors on the corticoidogenic re sponse to Bt2cAMP is in the activation steps of the intacellular cholesterol supply system without any functional coupling to voltage dependent calcium channels.
